222 related articles for article (PubMed ID: 27246850)
1. The Clustered, Regularly Interspaced, Short Palindromic Repeats-associated Endonuclease 9 (CRISPR/Cas9)-created MDM2 T309G Mutation Enhances Vitreous-induced Expression of MDM2 and Proliferation and Survival of Cells.
Duan Y; Ma G; Huang X; D'Amore PA; Zhang F; Lei H
J Biol Chem; 2016 Jul; 291(31):16339-47. PubMed ID: 27246850
[TBL] [Abstract][Full Text] [Related]
2. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.
Zhou G; Duan Y; Ma G; Wu W; Hu Z; Chen N; Chee Y; Cui J; Samad A; Matsubara JA; Mukai S; D'Amore PA; Lei H
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5361-5367. PubMed ID: 29049737
[TBL] [Abstract][Full Text] [Related]
3. Inactive Cas9 blocks vitreous-induced expression of Mdm2 and proliferation and survival of retinal pigment epithelial cells.
Chen N; Hu Z; Yang Y; Han H; Lei H
Exp Eye Res; 2019 Sep; 186():107716. PubMed ID: 31278903
[TBL] [Abstract][Full Text] [Related]
4. Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells.
Liu B; Song J; Han H; Hu Z; Chen N; Cui J; Matsubara JA; Zhong J; Lei H
Lab Invest; 2019 Dec; 99(12):1874-1886. PubMed ID: 31439892
[TBL] [Abstract][Full Text] [Related]
5. Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.
Han H; Chen N; Huang X; Liu B; Tian J; Lei H
J Biol Chem; 2019 Oct; 294(42):15408-15417. PubMed ID: 31467081
[TBL] [Abstract][Full Text] [Related]
6. The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.
Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutiérrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon Y; Harsum S; MacLaren RE; Charteris D; VanMeurs JC; González-Sarmiento R; Pastor JC;
PLoS One; 2013; 8(12):e82283. PubMed ID: 24349246
[TBL] [Abstract][Full Text] [Related]
7. Single-nucleotide polymorphisms p53 G72C and Mdm2 T309G in patients with psoriasis, psoriatic arthritis, and SAPHO syndrome.
Assmann G; Wagner AD; Monika M; Pfoehler C; Pfreundschuh M; Tilgen W; Roemer K
Rheumatol Int; 2010 Aug; 30(10):1273-6. PubMed ID: 19779722
[TBL] [Abstract][Full Text] [Related]
8. The
Jiang H; Yan B; Meng Z; Zhang L; Lei H; Luo J
Front Cell Dev Biol; 2022; 10():841660. PubMed ID: 35359434
[No Abstract] [Full Text] [Related]
9. AAV-Mediated CRISPR/Cas Gene Editing of Retinal Cells In Vivo.
Hung SS; Chrysostomou V; Li F; Lim JK; Wang JH; Powell JE; Tu L; Daniszewski M; Lo C; Wong RC; Crowston JG; Pébay A; King AE; Bui BV; Liu GS; Hewitt AW
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3470-6. PubMed ID: 27367513
[TBL] [Abstract][Full Text] [Related]
10. The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.
Cai X; Yang M
J Cancer Res Clin Oncol; 2012 Apr; 138(4):555-61. PubMed ID: 22205265
[TBL] [Abstract][Full Text] [Related]
11. AAV-CRISPR/Cas9-Mediated Depletion of VEGFR2 Blocks Angiogenesis In Vitro.
Wu W; Duan Y; Ma G; Zhou G; Park-Windhol C; D'Amore PA; Lei H
Invest Ophthalmol Vis Sci; 2017 Dec; 58(14):6082-6090. PubMed ID: 29204648
[TBL] [Abstract][Full Text] [Related]
12. The p53 G72C and MDM2 T309G single nucleotide polymorphisms in patients with Wegener's granulomatosis.
Assmann G; Wieczorek S; Wibisono D; Roemer K; Arning L; Voswinkel J
Clin Exp Rheumatol; 2008; 26(3 Suppl 49):S72-5. PubMed ID: 18799058
[TBL] [Abstract][Full Text] [Related]
13. Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR)/CRISPR-Associated Endonuclease Cas9-Mediated Homology-Independent Integration for Generating Quality Control Materials for Clinical Molecular Genetic Testing.
Lin G; Zhang K; Peng R; Han Y; Xie J; Li J
J Mol Diagn; 2018 May; 20(3):373-380. PubMed ID: 29680088
[TBL] [Abstract][Full Text] [Related]
14. The association between the T309G polymorphism of the MDM2 gene and sensitivity to anticancer drug is dependent on the p53 mutational status in cellular models.
Faur N; Araud L; Laroche-Clary A; Kanno J; Toutain J; Yamori T; Robert J; Le Morvan V
Br J Cancer; 2009 Jul; 101(2):350-6. PubMed ID: 19513075
[TBL] [Abstract][Full Text] [Related]
15. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.
Swiech L; Heidenreich M; Banerjee A; Habib N; Li Y; Trombetta J; Sur M; Zhang F
Nat Biotechnol; 2015 Jan; 33(1):102-6. PubMed ID: 25326897
[TBL] [Abstract][Full Text] [Related]
16. The association of polymorphic markers Arg399Gln of XRCC1 gene, Arg72Pro of TP53 gene and T309G of MDM2 gene with breast cancer in Kyrgyz females.
Isakova J; Talaibekova E; Aldasheva N; Vinnikov D; Aldashev A
BMC Cancer; 2017 Nov; 17(1):758. PubMed ID: 29132330
[TBL] [Abstract][Full Text] [Related]
17. Bacterial CRISPR/Cas DNA endonucleases: A revolutionary technology that could dramatically impact viral research and treatment.
Kennedy EM; Cullen BR
Virology; 2015 May; 479-480():213-20. PubMed ID: 25759096
[TBL] [Abstract][Full Text] [Related]
18. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer.
Yang M; Guo Y; Zhang X; Miao X; Tan W; Sun T; Zhao D; Yu D; Liu J; Lin D
Carcinogenesis; 2007 Sep; 28(9):1996-2001. PubMed ID: 17638920
[TBL] [Abstract][Full Text] [Related]
19. MDM2 T309G has a synergistic effect with P21 ser31arg single nucleotide polymorphisms on the risk of acute myeloid leukemia.
Ebid GT; Sedhom IA; El-Gammal MM; Moneer MM
Asian Pac J Cancer Prev; 2012; 13(9):4315-20. PubMed ID: 23167335
[TBL] [Abstract][Full Text] [Related]
20. Fusion of SpCas9 to E. coli Rec A protein enhances CRISPR-Cas9 mediated gene knockout in mammalian cells.
Lin L; Petersen TS; Jensen KT; Bolund L; Kühn R; Luo Y
J Biotechnol; 2017 Apr; 247():42-49. PubMed ID: 28259533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
